Yıldız, A. et al. 2025. Assessment of thrombin-activatable fibrinolysis inhibitor levels in essential hypertension. The European Research Journal. 11, 1 (Jan. 2025), 1–10. DOI:https://doi.org/10.18621/eurj.1501230.